Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:bcr09.2009.2237.
doi: 10.1136/bcr.09.2009.2237. Epub 2009 Dec 1.

Solitary ring enhancing brain lesion in a patient with AIDS

Taha Aldeen  1 , Michael Lunn
Affiliations

Solitary ring enhancing brain lesion in a patient with AIDS

Taha Aldeen et al. BMJ Case Rep. 2009.

Abstract

Toxoplasmosis in immune competent patients usually causes asymptomatic infection or mild symptoms, while in immunocompromised and AIDS patients it can be a life threatening condition. We report a case of cerebral toxoplasmosis in a patient with AIDS and review the causes of brain ring enhancing lesions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient’s brain MRI before treatment (left image) and 18 months after HAART and anti-toxoplasmosis therapy (right image).
See this image and copyright information in PMC

References

    1. Schroeder PC, Post MJ, Oschatz E, et al. Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 2006; 48: 715–20 - PubMed
    1. Cunha BA. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am 2001; 15: 567–90 - PubMed
    1. Rosenow JM, Hirschfeld A. Utility of brain biopsy in patients with acquired immunodeficiency syndrome before and after introduction of highly active antiretroviral therapy. Neurosurgery 2007; 61: 130–41 - PubMed
    1. Antinori A, Larussa D, Cingolani A, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 1681–91 - PubMed
    1. Katlama C, De Wit S, O’Doherty E, et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996; 22: 268–75 - PubMed

LinkOut - more resources